Medico Remedies Limited (MEDICO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Medico Remedies Limited (MEDICO) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs6.43 Million ≈ $69.54K USD) by net assets (Rs668.58 Million ≈ $7.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MEDICO days of operational coverage to measure how many days the company can operate on defensive assets alone.

Medico Remedies Limited - Cash Flow Conversion Efficiency Trend (2013–2026)

This chart illustrates how Medico Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Medico Remedies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medico Remedies Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Blackboxstocks Inc
NASDAQ:BLBX
-0.090x
Sepeda Bersama Indonesia Tbk PT
JK:BIKE
-0.079x
Hojeon Ltd
KO:111110
0.074x
Toplus Global Co Ltd
TWO:3522
0.184x
INFOMARK Co. Ltd
KQ:175140
0.067x
Anteotech Ltd
AU:ADO
-0.264x
CESSATECH A/S DK -20
F:8GN
-0.025x
First Graphene Ltd
AU:FGR
-0.095x

Annual Cash Flow Conversion Efficiency for Medico Remedies Limited (2013–2026)

The table below shows the annual cash flow conversion efficiency of Medico Remedies Limited from 2013 to 2026. For the full company profile with market capitalisation and key ratios, see how much is Medico Remedies Limited worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs754.74 Million
≈ $8.16 Million
Rs10.06 Million
≈ $108.82K
0.013x -82.98%
2025-03-31 Rs624.69 Million
≈ $6.76 Million
Rs48.92 Million
≈ $529.06K
0.078x +68.23%
2024-03-31 Rs523.71 Million
≈ $5.66 Million
Rs24.38 Million
≈ $263.65K
0.047x -75.01%
2023-03-31 Rs438.43 Million
≈ $4.74 Million
Rs81.67 Million
≈ $883.25K
0.186x +18.60%
2022-03-31 Rs373.20 Million
≈ $4.04 Million
Rs58.62 Million
≈ $633.95K
0.157x +145.08%
2021-03-31 Rs324.58 Million
≈ $3.51 Million
Rs-113.10 Million
≈ $-1.22 Million
-0.348x -1175.78%
2020-03-31 Rs298.66 Million
≈ $3.23 Million
Rs9.67 Million
≈ $104.62K
0.032x -81.43%
2019-03-31 Rs282.36 Million
≈ $3.05 Million
Rs49.24 Million
≈ $532.54K
0.174x -8.75%
2018-03-31 Rs266.66 Million
≈ $2.88 Million
Rs50.97 Million
≈ $551.17K
0.191x +202.51%
2017-03-31 Rs163.72 Million
≈ $1.77 Million
Rs-30.52 Million
≈ $-330.12K
-0.186x +26.28%
2016-03-31 Rs147.44 Million
≈ $1.59 Million
Rs-37.29 Million
≈ $-403.27K
-0.253x -980.71%
2015-03-31 Rs136.14 Million
≈ $1.47 Million
Rs-3.19 Million
≈ $-34.46K
-0.023x -107.36%
2014-03-31 Rs85.72 Million
≈ $927.00K
Rs27.27 Million
≈ $294.96K
0.318x -21.78%
2013-03-31 Rs50.55 Million
≈ $546.71K
Rs20.57 Million
≈ $222.40K
0.407x --

About Medico Remedies Limited

NSE:MEDICO India Drug Manufacturers - Specialty & Generic
Market Cap
$38.65 Million
Rs3.57 Billion INR
Market Cap Rank
#22894 Global
#1273 in India
Share Price
Rs43.07
Change (1 day)
+0.33%
52-Week Range
Rs32.76 - Rs54.24
All Time High
Rs96.70
About

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more